Clinical data on the course of sub-centimeter-sized nodules (SCSNs) detected during surveillance for HCC is limited. Through this study we wished to evaluate arterially enhancing SCSN evolving into HCC. We tried identify specific size cut off, rate of growth, enhancement features which can predict which SCSN will turn into HCC. 47.5% of SCSN have the potential to turn into HCC. 8.55 mm is the optimal size cut off above which risk of developing HCC increases with a sensitivity of 71.4%. Diffusion restriction was seen in 50% and non uptake of hepatobiliary contrast in 91% of SCSN which developed into HCC.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords